[go: up one dir, main page]

AR002459A1 - TRASCINIC BENZACEPINE VASOPRESIN ANTAGONISTS, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, A METHOD FOR TREATING DISEASES AND A PROCEDURE FOR THEIR PREPARATION. - Google Patents

TRASCINIC BENZACEPINE VASOPRESIN ANTAGONISTS, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, A METHOD FOR TREATING DISEASES AND A PROCEDURE FOR THEIR PREPARATION.

Info

Publication number
AR002459A1
AR002459A1 ARP960101027A AR10102796A AR002459A1 AR 002459 A1 AR002459 A1 AR 002459A1 AR P960101027 A ARP960101027 A AR P960101027A AR 10102796 A AR10102796 A AR 10102796A AR 002459 A1 AR002459 A1 AR 002459A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
antagonists
trascinic
benzacepine
vasopresin
Prior art date
Application number
ARP960101027A
Other languages
Spanish (es)
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/548,805 external-priority patent/US5849735A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of AR002459A1 publication Critical patent/AR002459A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/20—Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C07D223/28—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/38—[b, e]- or [b, f]-condensed with six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/16—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D267/20—[b, f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Antagonistas de vasopresina de benzacepina tricíclicos que tienen la fórmula general (I), definidos en la memoria descriptiva que exhiben actividadantagonista en receptores V1 y/o V2 y exhiben actividad antagonista de vasopresina inv ivo, métodos para usar dichos compuestos para tratarenfermedades caracterizadas por un exceso de reabsorción renal de agua, procedimientos para preparar dichos compuestos y una composición farmacéuticaque los contiene.Tricyclic benzazepine vasopressin antagonists having the general formula (I), defined in the specification that exhibit antagonistic activity at V1 and / or V2 receptors and exhibit inv ivo vasopressin antagonist activity, methods for using such compounds to treat diseases characterized by excess of renal water reabsorption, processes for preparing said compounds and a pharmaceutical composition containing them.

ARP960101027A 1995-01-17 1996-01-15 TRASCINIC BENZACEPINE VASOPRESIN ANTAGONISTS, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, A METHOD FOR TREATING DISEASES AND A PROCEDURE FOR THEIR PREPARATION. AR002459A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37316995A 1995-01-17 1995-01-17
US08/548,805 US5849735A (en) 1995-01-17 1995-12-22 Tricyclic benzazepine vasopressin antagonists

Publications (1)

Publication Number Publication Date
AR002459A1 true AR002459A1 (en) 1998-03-25

Family

ID=27006077

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960101027A AR002459A1 (en) 1995-01-17 1996-01-15 TRASCINIC BENZACEPINE VASOPRESIN ANTAGONISTS, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, A METHOD FOR TREATING DISEASES AND A PROCEDURE FOR THEIR PREPARATION.

Country Status (14)

Country Link
EP (1) EP0804420A1 (en)
JP (1) JPH10512865A (en)
CN (1) CN1190391A (en)
AR (1) AR002459A1 (en)
AU (1) AU4904296A (en)
BR (1) BR9606977A (en)
CA (1) CA2210688A1 (en)
CZ (1) CZ224597A3 (en)
EA (1) EA000752B1 (en)
HU (1) HUP9801219A3 (en)
IL (1) IL116777A (en)
NZ (1) NZ302881A (en)
TW (1) TW449584B (en)
WO (1) WO1996022282A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693635A (en) * 1993-07-29 1997-12-02 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
AU3296497A (en) * 1996-06-13 1998-01-07 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
AU8592598A (en) * 1997-07-30 1999-02-22 Wyeth Tricyclic vasopressin agonists
US6194407B1 (en) 1997-07-30 2001-02-27 American Home Products Corporation Tricyclic pyrido vasopressin agonists
AR018818A1 (en) * 1998-04-03 2001-12-12 Yamano Masaki A PHARMACEUTICAL COMPOSITION FOR THE THERAPY OF AN EDEMA.
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US6090803A (en) * 1998-07-24 2000-07-18 American Home Products Corporation Tricyclic vasopressin agonists
US6297234B1 (en) 1999-02-04 2001-10-02 American Home Products Corporation Arylthiophene vasopressin agonists
AU6870500A (en) * 1999-09-06 2001-04-10 Takeda Chemical Industries Ltd. Process for the preparation of 2,3-dihydroazepine derivatives
US7064120B2 (en) * 2001-04-12 2006-06-20 Wyeth Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7326700B2 (en) 2001-04-12 2008-02-05 Wyeth Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US7109193B2 (en) 2001-04-12 2006-09-19 Wyeth Tricyclic diazepines tocolytic oxytocin receptor antagonists
US6900200B2 (en) 2001-04-12 2005-05-31 Wyeth Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
EP1381370B1 (en) 2001-04-12 2007-03-07 Wyeth N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
DK1381608T3 (en) 2001-04-12 2008-02-04 Wyeth Corp Cyclohexylphenyl vasopressin agonists
US6977254B2 (en) 2001-04-12 2005-12-20 Wyeth Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US7202239B2 (en) 2001-04-12 2007-04-10 Wyeth Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
SE0102299D0 (en) * 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (en) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
RU2266906C1 (en) * 2004-04-29 2005-12-27 Общество с ограниченной ответственностью "Исследовательский Институт Химического Разнообразия" (ООО "Исследовательский Институт Химического Разнообразия") Anellated carbamoyl azaheterocycles, methods for their preparing (variants), pharmaceutical composition, focused library
EP2301935A1 (en) 2005-07-09 2011-03-30 AstraZeneca AB (Publ) Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
PE20080145A1 (en) 2006-03-21 2008-02-11 Janssen Pharmaceutica Nv TETRAHYDRO-PYRIMIDOAZEPINE AS MODULATORS OF TRPV1
JP5385299B2 (en) * 2007-12-05 2014-01-08 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Dibenzazepine and dibenzoxazepine TRPA1 agonist
US8288397B2 (en) 2007-12-17 2012-10-16 Janssen Pharmaceutica Nv Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1
WO2010116176A1 (en) 2009-04-09 2010-10-14 Astrazeneca Ab Pyrazolo [4, 5-e] pyrimidine derivative and its use to treat diabetes and obesity
EP3116509B1 (en) * 2014-03-12 2022-06-22 The Trustees of Columbia University in the City of New York A new class of mu-opioid receptor agonists
TWI698430B (en) * 2015-02-13 2020-07-11 南北兄弟藥業投資有限公司 Tricyclic compounds and uses thereof in medicine
RU2019120162A (en) * 2016-12-12 2021-01-12 Де Юниверсити Оф Сидней Non-peptide oxytocin receptor agonists
ES3008911T3 (en) 2017-07-11 2025-03-25 Vertex Pharma Carboxamides as modulators of sodium channels
WO2020146612A1 (en) 2019-01-10 2020-07-16 Vertex Pharmaceuticals Incorporated Esters and carbamates as modulators of sodium channels
US12441703B2 (en) 2019-01-10 2025-10-14 Vertex Pharmaceuticals Incorporated Carboxamides as modulators of sodium channels
PE20230608A1 (en) 2020-05-05 2023-04-13 Nuvalent Inc HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPY
EP4146205A4 (en) 2020-05-05 2024-05-29 Nuvalent, Inc. HETEROAROMATIC MACROCYCLIC ETHER-BASED CHEMOTHERAPY AGENTS
CN118234725A (en) 2021-10-01 2024-06-21 纽威伦特公司 Solid forms, pharmaceutical compositions and preparations of heteroaromatic macrocyclic ether compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
DE69026708T2 (en) * 1989-10-20 1997-04-03 Otsuka Pharma Co Ltd BENZOHETEROCYCLIC COMPOUNDS
GB9307527D0 (en) * 1993-04-13 1993-06-02 Fujisawa Pharmaceutical Co New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
ATE239726T1 (en) * 1993-07-21 2003-05-15 Yamanouchi Pharma Co Ltd FUSED BENZAZEPINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME
US5512563A (en) * 1993-07-29 1996-04-30 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
US5516774A (en) * 1993-07-29 1996-05-14 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists

Also Published As

Publication number Publication date
JPH10512865A (en) 1998-12-08
HUP9801219A2 (en) 1998-10-28
IL116777A (en) 2000-11-21
EP0804420A1 (en) 1997-11-05
HUP9801219A3 (en) 2000-07-28
CZ224597A3 (en) 1997-12-17
BR9606977A (en) 1997-11-04
EA000752B1 (en) 2000-04-24
AU4904296A (en) 1996-08-07
CA2210688A1 (en) 1996-07-25
EA199700116A1 (en) 1997-12-30
NZ302881A (en) 1999-03-29
TW449584B (en) 2001-08-11
WO1996022282A1 (en) 1996-07-25
IL116777A0 (en) 1996-05-14
CN1190391A (en) 1998-08-12

Similar Documents

Publication Publication Date Title
AR002459A1 (en) TRASCINIC BENZACEPINE VASOPRESIN ANTAGONISTS, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, A METHOD FOR TREATING DISEASES AND A PROCEDURE FOR THEIR PREPARATION.
ECSP941135A (en) BENZACEPINE VASOPRESSIN TRICYCLIC ANTAGONISTS
AR002268A1 (en) BENZACEPINE TRICYCLIC VASOPRESIN ANTAGONISTS, A PROCEDURE FOR THEIR PREPARATION, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND THE USE OF SUCH COMPOUNDS TO PREPARE PHARMACEUTICAL COMPOSITIONS.
EA199700117A1 (en) TRICYCLIC BENZE-GOLDEN ANTAGONISTS VAZOPRESSIN, METHOD FOR THEIR RECOVERY, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT OF MAMMALS USING Tricyclic Benzene
ES2163407T3 (en) Thiacyclic PIPERIDINYL DERIVATIVES.
MX9401191A (en) SULFAMOIL AND AMIDINE GROUP COMPOUNDS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
BG101806A (en) INDOLE DERIVATIVES AS ANTAGONISTS OF 5-N RECEPTORS
MXPA99000214A (en) Tricyclic benzazepine vasopressin antagonists.
PE20020521A1 (en) SUBSTITUTE HETEROCYCLIC COMPOUNDS TO TREAT MULTIPLE DRUG RESISTANCE
ES2170211T3 (en) AZAHETEROCICLIC COMPOUNDS THAT HAVE ANTAGONIST ACTIVITY OF TAQUIQUININE RECEIVERS; NK1 AND NK2.
DK0840732T3 (en) Substituted benzolactam compounds as substance P antagonists
DE69507029D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING AN OPIATE ANTAGONIST AND CALCIUM SALTS, THEIR USE FOR TREATING ENDORPHINE-MEDIATED DISEASES
BR0113980A (en) Fused heterocyclic succinimide compounds and their analogs, modulators of nuclear hormone receptor function
DE69525847D1 (en) COMPOSITIONS OF OPIOID ANTAGONISTS WITH SELECTIVE SEROTONIN INHIBITORS, FOR THE TREATMENT OF ALCOHOLISM AND ALCOHOL DEPENDENCY
ATE230993T1 (en) PHARMACEUTICAL COMPOSITION FOR TREATING ALCOHOL DEPENDENCE CONTAINING OPIOID ANTAGONISTS WITH NMDA RECEPTOR COMPLEX MODULATORS
EA200200207A1 (en) APPLICATION OF CGRP ANTAGONISTS AND CGRP RELIEF INHIBITORS TO ELIMINATE TIDES IN THE PERIOD OF MENOPAUSE
ES2173294T3 (en) NEW MEDICAL USE.
DK1109814T3 (en) 5-Heterocyclylpyrazolo [4,3-d] pyrimidin-7-ones for the treatment of male erectile dysfunction
DK0758312T3 (en) Substituted fused and bridged bicyclic compounds as therapeutic agents
NO990322L (en) Pharmaceutical mixture containing a 5HT2c antagonist and a D2 antagonist
BR9812002A (en) Compounds with anti-first pass effect
DK0648117T3 (en) Drug to prevent development of tolerance in treatment with benzodiazepine receptor binding active compounds
EA199901049A2 (en) Spiro imidazoline compounds, a process for their preparation and pharmaceutical composition containing them
MX9301870A (en) ANGIOTENSIN II RECEPTOR ANTAGONISTS
UY26509A1 (en) SUBSTITUTED PYRROLYTIC BASES FOR MANNICH, PROCEDURE FOR THE PREPARATION, MEDICINES CONTAINING THESE COMPOUNDS, AND USE OF THE COMPOUND FOR THE PREPARATION OF MEDICINES.